Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News St Jude Medical receives EU approval for EnligHTN system

St Jude Medical receives EU approval for EnligHTN system

3rd September 2013

St Jude Medical has been granted European CE Mark approval for its next-generation EnligHTN renal denervation system.

The device has been approved for use in the treatment of patients with drug-resistant, uncontrolled hypertension, with studies showing that it is able to reduce total ablation time by more than 80 percent.

It features an advanced generator that delivers simultaneous ablations via a multi-electrode catheter and is currently being evaluated in the EnligHTN III study to further demonstrate its clinical benefits.

This week, the manufacturer is demonstrating its various features and benefits to attendees of the 2013 European Society of Cardiology Congress in Amsterdam.

Frank Callaghan, president of the St Jude Medical cardiovascular and ablation technologies division, said: "The next generation EnligHTN system offers physicians our proven multi-electrode catheter with a new intuitive, faster generator that quickly and effectively delivers consistent ablations with a significant reduction in procedure time."

Last month, the firm announced that it will be expanding its business capabilities with the acquisition of Endosense, a leading Swiss medical technology firm.ADNFCR-8000103-ID-801633187-ADNFCR

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.